Blog

Healthcare workers collaborating on a laptop and mobile device.

Leveraging Technology to Improve Specialty Pharmacy Engagement

Specialty pharmacies (SPs) play a crucial role in delivering complex medications to patients who require ongoing support throughout their treatment journeys. However, the effectiveness of SPs often hinges on timely intervention, efficiency, and seamless collaboration among stakeholders. These challenges are further amplified by time-consuming manual processes, delayed responses, and lack of real-time visibility into patient […]

Leveraging Technology to Improve Specialty Pharmacy Engagement Read More »

In a modern workspace, team members analyze data trends displayed on their devices, highlighting the significance of collaborative decision-making in business growth. The laptop and tablet showcase detailed graphs, emphasizing the importance of technology in understanding market dynamics.

Empowering Patient Services: Addressing Drop-Offs with the Claritas Rx Patient Watchtower

Guiding patients through their treatment journey is a critical yet intricate task for patient services teams. One of the biggest obstacles they face is “patient drop-off,” the moments when individuals disengage or discontinue treatment. These drop-offs can significantly impact healthcare outcomes, operational efficiency, and access to care. This blog explores the key stages in the

Empowering Patient Services: Addressing Drop-Offs with the Claritas Rx Patient Watchtower Read More »

A doctor holds a glowing light bulb, symbolizing bright ideas and the promise of a healthier future.

A Breakthrough in Vision Care: The FDA Approval of Neurotech’s Encelto for Macular Telangiectasia Type 2

Macular telangiectasia (MacTel) type 2, a rare neurodegenerative eye condition, has long left many without access to effective treatment. This disease silently affects central vision, making everyday tasks like reading and recognizing faces increasingly challenging for those impacted. However, patients and biopharma professionals alike have reason to look ahead with renewed optimism. On March 6,

A Breakthrough in Vision Care: The FDA Approval of Neurotech’s Encelto for Macular Telangiectasia Type 2 Read More »

Closeup of a healthcare employee or caregiver with a senior patient on technology for health tips.

Shaping the Future of Rare Disease Treatment – How You Can Contribute

The treatment landscape for rare diseases is rapidly evolving, offering both opportunities and challenges for biopharma professionals and patient service teams. With over 7,000 known rare diseases affecting an estimated 300 million people globally, the need for innovation and collaboration has never been greater. Yet, rare diseases are often underfunded, understudied, and misunderstood, leaving many

Shaping the Future of Rare Disease Treatment – How You Can Contribute Read More »

In a modern clinic, a healthcare professional engages with advanced technology, exploring artificial intelligence applications for patient care. Surrounded by symbols of health and wellness, they strive to enhance medical outcomes through digital innovation.

The Future of Rare Disease Treatment: How AI Is Transforming Patient Data Management

Rare diseases affect approximately 30 million people in the United States, yet the path to diagnosing and treating these conditions remains notoriously complex. With small patient populations, high treatment costs, and the necessity for robust engagement strategies, the rare disease sector is filled with challenges. For biopharma professionals, the focus remains on finding innovative ways

The Future of Rare Disease Treatment: How AI Is Transforming Patient Data Management Read More »

In a modern workspace, a digital representation of a DNA double helix floats above a sleek computer monitor, suggesting a blend of technology and biology. The scene is illuminated with soft, ambient lighting, creating an inspiring atmosphere for scientific discovery.

Emerging Market Access Trends in Cell and Gene Therapies for Rare Diseases

The landscape of rare diseases is evolving rapidly, with groundbreaking cell and gene therapies leading the way. These innovative treatments offer hope to patients with diseases previously considered untreatable. However, with innovation comes complexity—bringing these therapies to market isn’t just about scientific breakthroughs but also navigating unique market access challenges. This blog dives into the

Emerging Market Access Trends in Cell and Gene Therapies for Rare Diseases Read More »

Medical doctor using mobile phone and consulting

The Future of Patient Support Services: Insights from Industry Leaders

Understanding how data and technology intersect with patient support services is essential for teams striving to improve patient outcomes. At the recent Access Patient Support Services Congress, a panel discussion titled “Optimizing Patient Services — Leveraging Data and Technology to Improve Patient Programs” gathered experienced leaders in patient services to share their valuable insights on

The Future of Patient Support Services: Insights from Industry Leaders Read More »

Close-up of hand holding a pill bottle and writing prescription

Innovation, Acquisition, and the Future of Oncology: Unraveling Eli Lilly’s Strategic Move

Eli Lilly has consistently demonstrated its dedication to precision oncology, and its latest acquisition is a testament to that commitment. The biopharma giant announced a $2.5 billion deal with Scorpion Therapeutics to acquire an experimental cancer drug targeting PI3Kα mutations. This strategic move positions Lilly to further advance its oncology portfolio and address significant unmet

Innovation, Acquisition, and the Future of Oncology: Unraveling Eli Lilly’s Strategic Move Read More »

Businessman computing at his workplace

Benchmarking Success: Leveraging Fill Rate and Time-to-Fill for Enhanced Market Access in 2025

Market access in the biopharma industry goes beyond delivering innovative therapies—it’s about ensuring patients receive timely and seamless access to those treatments. Two key metrics, fill rate and time-to-fill, have emerged as essential benchmarks for assessing operational efficiency, improving patient access, and aligning with strategic goals. But how can biopharma professionals effectively use these metrics

Benchmarking Success: Leveraging Fill Rate and Time-to-Fill for Enhanced Market Access in 2025 Read More »